The central chemoreceptors increase ventilation in response to an increase in H+ in the brain interstitial fluid.

The Control of Ventilation in the Human Body

The control of ventilation in the human body is a complex process that involves various components working together to regulate the respiratory rate and depth of respiration. The respiratory centres, chemoreceptors, lung receptors, and muscles all play a role in this process. The automatic, involuntary control of respiration occurs from the medulla, which is responsible for controlling the respiratory rate and depth of respiration.

The respiratory centres consist of the medullary respiratory centre, apneustic centre, and pneumotaxic centre. The medullary respiratory centre has two groups of neurons, the ventral group, which controls forced voluntary expiration, and the dorsal group, which controls inspiration. The apneustic centre, located in the lower pons, stimulates inspiration and activates and prolongs inhalation. The pneumotaxic centre, located in the upper pons, inhibits inspiration at a certain point and fine-tunes the respiratory rate.

Ventilatory variables, such as the levels of pCO2, are the most important factors in ventilation control, while levels of O2 are less important. Peripheral chemoreceptors, located in the bifurcation of carotid arteries and arch of the aorta, respond to changes in reduced pO2, increased H+, and increased pCO2 in arterial blood. Central chemoreceptors, located in the medulla, respond to increased H+ in brain interstitial fluid to increase ventilation. It is important to note that the central receptors are not influenced by O2 levels.

Lung receptors also play a role in the control of ventilation. Stretch receptors respond to lung stretching, causing a reduced respiratory rate, while irritant receptors respond to smoke, causing bronchospasm. J (juxtacapillary) receptors are also involved in the control of ventilation. Overall, the control of ventilation is a complex process that involves various components working together to regulate the respiratory rate and depth of respiration.

The chloride channel, specifically a cyclic-AMP regulated chloride channel, is the correct answer. Cystic fibrosis can be caused by various mutations, but they all affect the same gene, the cystic fibrosis transmembrane conductance regulator gene. This gene encodes a chloride channel that, when dysfunctional, results in increased viscosity of secretions and the development of cystic fibrosis.

Understanding Cystic Fibrosis

Cystic fibrosis is a genetic disorder that causes thickened secretions in the lungs and pancreas. It is an autosomal recessive condition that occurs due to a defect in the cystic fibrosis transmembrane conductance regulator gene (CFTR), which regulates a chloride channel. In the UK, 80% of CF cases are caused by delta F508 on chromosome 7, and the carrier rate is approximately 1 in 25.

CF patients are at risk of colonization by certain organisms, including Staphylococcus aureus, Pseudomonas aeruginosa, Burkholderia cepacia (previously known as Pseudomonas cepacia), and Aspergillus. These organisms can cause infections and exacerbate symptoms in CF patients. It is important for healthcare providers to monitor and manage these infections to prevent further complications.

Overall, understanding cystic fibrosis and its associated risks can help healthcare providers provide better care for patients with this condition.

The most effective intervention to slow the decrease in FEV1 experienced by patients with COPD is to stop smoking. If the patient has no asthmatic/steroid-responsive features, the next step in management would be to add a long-acting beta2-agonist (LABA) and a long-acting muscarinic antagonist. If the patient has asthmatic/steroid-responsive features, the next step would be to add a LABA and an inhaled corticosteroid. Oral theophylline is only considered if inhaled therapy is not possible, and oral prednisolone is only used during acute infective exacerbations of COPD to help with inflammation and is not a long-term solution to slow the reduction of FEV1.

The National Institute for Health and Care Excellence (NICE) updated its guidelines on the management of chronic obstructive pulmonary disease (COPD) in 2018. The guidelines recommend general management strategies such as smoking cessation advice, annual influenzae vaccination, and one-off pneumococcal vaccination. Pulmonary rehabilitation is also recommended for patients who view themselves as functionally disabled by COPD.

Bronchodilator therapy is the first-line treatment for patients who remain breathless or have exacerbations despite using short-acting bronchodilators. The next step is determined by whether the patient has asthmatic features or features suggesting steroid responsiveness. NICE suggests several criteria to determine this, including a previous diagnosis of asthma or atopy, a higher blood eosinophil count, substantial variation in FEV1 over time, and substantial diurnal variation in peak expiratory flow.

If the patient does not have asthmatic features or features suggesting steroid responsiveness, a long-acting beta2-agonist (LABA) and long-acting muscarinic antagonist (LAMA) should be added. If the patient is already taking a short-acting muscarinic antagonist (SAMA), it should be discontinued and switched to a short-acting beta2-agonist (SABA). If the patient has asthmatic features or features suggesting steroid responsiveness, a LABA and inhaled corticosteroid (ICS) should be added. If the patient remains breathless or has exacerbations, triple therapy (LAMA + LABA + ICS) should be offered.

NICE only recommends theophylline after trials of short and long-acting bronchodilators or to people who cannot use inhaled therapy. Azithromycin prophylaxis is recommended in select patients who have optimised standard treatments and continue to have exacerbations. Mucolytics should be considered in patients with a chronic productive cough and continued if symptoms improve.

Cor pulmonale features include peripheral oedema, raised jugular venous pressure, systolic parasternal heave, and loud P2. Loop diuretics should be used for oedema, and long-term oxygen therapy should be considered. Smoking cessation, long-term oxygen therapy in eligible patients, and lung volume reduction surgery in selected patients may improve survival in patients with stable COPD. NICE does not recommend the use of ACE-inhibitors, calcium channel blockers, or alpha blockers

The raised transfer factor suggests that the patient is experiencing an exacerbation of asthma. This condition can cause obstructive patterns on pulmonary function tests, leading to reduced FEV1 and FEV1/FVC, as well as hypoxia and wheezing. However, other conditions such as COPD exacerbation, idiopathic pulmonary fibrosis, and pulmonary embolism would result in a low transfer factor, and are therefore unlikely explanations for the patient’s symptoms.

Understanding Transfer Factor in Lung Function Testing

The transfer factor is a measure of how quickly a gas diffuses from the alveoli into the bloodstream. This is typically tested using carbon monoxide, and the results can be given as either the total gas transfer (TLCO) or the transfer coefficient corrected for lung volume (KCO). A raised TLCO may be caused by conditions such as asthma, pulmonary haemorrhage, left-to-right cardiac shunts, polycythaemia, hyperkinetic states, male gender, or exercise. On the other hand, a lower TLCO may be indicative of pulmonary fibrosis, pneumonia, pulmonary emboli, pulmonary oedema, emphysema, anaemia, or low cardiac output.

KCO tends to increase with age, and certain conditions may cause an increased KCO with a normal or reduced TLCO. These conditions include pneumonectomy/lobectomy, scoliosis/kyphosis, neuromuscular weakness, and ankylosis of costovertebral joints (such as in ankylosing spondylitis). Understanding transfer factor is important in lung function testing, as it can provide valuable information about a patient’s respiratory health and help guide treatment decisions.

Cholesteatoma is a growth of non-cancerous squamous epithelium that can be observed as an ‘attic crust’ during otoscopy. This patient is displaying symptoms consistent with cholesteatoma, including ear discharge, earache, conductive hearing loss, and dizziness, which suggests that the inner ear has also been affected. It is important to distinguish cholesteatoma from otitis externa, as failure to diagnose cholesteatoma can lead to serious complications. Cholesteatoma can erode the ossicles bones, damage the inner ear and vestibulocochlear nerve, and even result in brain infections if it erodes through the skull bone.

Otitis externa is an inflammation of the outer ear canal that causes ear pain, which worsens with movement of the outer ear. It is often caused by the use of earplugs or swimming in unclean water. Otitis media is an inflammation of the middle ear that can lead to fluid accumulation and perforation of the tympanic membrane. It is common in children and often follows a viral upper respiratory tract infection. Myringitis is a condition associated with otitis media that causes small vesicles or cysts to form on the surface of the eardrum, resulting in severe pain and hearing impairment. It is caused by viral or bacterial infections and is treated with pain relief and antibiotics.

Understanding Cholesteatoma

Cholesteatoma is a benign growth of squamous epithelium that can cause damage to the skull base. It is most commonly found in individuals between the ages of 10 and 20 years old. Those born with a cleft palate are at a higher risk of developing cholesteatoma, with a 100-fold increase in risk.

The main symptoms of cholesteatoma include a persistent discharge with a foul odor and hearing loss. Other symptoms may occur depending on the extent of the growth, such as vertigo, facial nerve palsy, and cerebellopontine angle syndrome.

During otoscopy, a characteristic attic crust may be seen in the uppermost part of the eardrum.

Management of cholesteatoma involves referral to an ear, nose, and throat specialist for surgical removal. Early detection and treatment are important to prevent further damage to the skull base and surrounding structures.

In summary, cholesteatoma is a non-cancerous growth that can cause significant damage if left untreated. It is important to be aware of the symptoms and seek medical attention promptly if they occur.

During pregnancy, a woman’s increased tidal volume leads to a decrease in carbon dioxide levels, resulting in alkalosis. This is because carbon dioxide generates acid, and reduced levels of it lead to a decrease in acid. The kidneys eventually adapt to this change by reducing the amount of alkaline bicarbonate in the body. Therefore, pregnancy causes a compensated respiratory alkalosis.

If a woman’s bicarbonate levels remain normal, she would have simple respiratory alkalosis.

On the other hand, if a woman produces excess acid, she would have metabolic acidosis, which is the opposite of what occurs during pregnancy.

Arterial Blood Gas Interpretation: A 5-Step Approach

Arterial blood gas interpretation is a crucial aspect of patient care, particularly in critical care settings. The Resuscitation Council (UK) recommends a 5-step approach to interpreting arterial blood gas results. The first step is to assess the patient’s overall condition. The second step is to determine if the patient is hypoxaemic, with a PaO2 on air of less than 10 kPa. The third step is to assess if the patient is acidaemic (pH <7.35) or alkalaemic (pH >7.45).

The fourth step is to evaluate the respiratory component of the arterial blood gas results. A PaCO2 level greater than 6.0 kPa suggests respiratory acidosis, while a PaCO2 level less than 4.7 kPa suggests respiratory alkalosis. The fifth step is to assess the metabolic component of the arterial blood gas results. A bicarbonate level less than 22 mmol/l or a base excess less than -2mmol/l suggests metabolic acidosis, while a bicarbonate level greater than 26 mmol/l or a base excess greater than +2mmol/l suggests metabolic alkalosis.

To remember the relationship between pH, PaCO2, and bicarbonate, the acronym ROME can be used. Respiratory acidosis or alkalosis is opposite to the pH level, while metabolic acidosis or alkalosis is equal to the pH level. This 5-step approach and the ROME acronym can aid healthcare professionals in interpreting arterial blood gas results accurately and efficiently.

The posterior and superior mediastinum contain the thoracic duct.

The mediastinum is the area located between the two pulmonary cavities and is covered by the mediastinal pleura. It extends from the thoracic inlet at the top to the diaphragm at the bottom. The mediastinum is divided into four regions: the superior mediastinum, middle mediastinum, posterior mediastinum, and anterior mediastinum.

The superior mediastinum is the area between the manubriosternal angle and T4/5. It contains important structures such as the superior vena cava, brachiocephalic veins, arch of aorta, thoracic duct, trachea, oesophagus, thymus, vagus nerve, left recurrent laryngeal nerve, and phrenic nerve. The anterior mediastinum contains thymic remnants, lymph nodes, and fat. The middle mediastinum contains the pericardium, heart, aortic root, arch of azygos vein, and main bronchi. The posterior mediastinum contains the oesophagus, thoracic aorta, azygos vein, thoracic duct, vagus nerve, sympathetic nerve trunks, and splanchnic nerves.

In summary, the mediastinum is a crucial area in the thorax that contains many important structures and is divided into four regions. Each region contains different structures that are essential for the proper functioning of the body.

The superior mesenteric artery originates from the abdominal aorta at the transpyloric plane, which is an imaginary axial plane located at the level of the L1 vertebral body and midway between the jugular notch and superior border of the pubic symphysis. Another transverse plane commonly used in anatomy is the subcostal plane, which passes through the 10th costal margin and the vertebral body L3. Additionally, the trans-tubercular plane, which is a horizontal plane passing through the iliac tubercles and in line with the 5th lumbar vertebrae, is often used to delineate abdominal regions in surface anatomy.

The Transpyloric Plane and its Anatomical Landmarks

The transpyloric plane is an imaginary horizontal line that passes through the body of the first lumbar vertebrae (L1) and the pylorus of the stomach. It is an important anatomical landmark used in clinical practice to locate various organs and structures in the abdomen.

Some of the structures that lie on the transpyloric plane include the left and right kidney hilum (with the left one being at the same level as L1), the fundus of the gallbladder, the neck of the pancreas, the duodenojejunal flexure, the superior mesenteric artery, and the portal vein. The left and right colic flexure, the root of the transverse mesocolon, and the second part of the duodenum also lie on this plane.

In addition, the upper part of the conus medullaris (the tapered end of the spinal cord) and the spleen are also located on the transpyloric plane. Knowing the location of these structures is important for various medical procedures, such as abdominal surgeries and diagnostic imaging.

Overall, the transpyloric plane serves as a useful reference point for clinicians to locate important anatomical structures in the abdomen.

Slowing the decrease in FEV1 in COPD can be most effectively achieved by quitting smoking.

The National Institute for Health and Care Excellence (NICE) updated its guidelines on the management of chronic obstructive pulmonary disease (COPD) in 2018. The guidelines recommend general management strategies such as smoking cessation advice, annual influenzae vaccination, and one-off pneumococcal vaccination. Pulmonary rehabilitation is also recommended for patients who view themselves as functionally disabled by COPD.

Bronchodilator therapy is the first-line treatment for patients who remain breathless or have exacerbations despite using short-acting bronchodilators. The next step is determined by whether the patient has asthmatic features or features suggesting steroid responsiveness. NICE suggests several criteria to determine this, including a previous diagnosis of asthma or atopy, a higher blood eosinophil count, substantial variation in FEV1 over time, and substantial diurnal variation in peak expiratory flow.

If the patient does not have asthmatic features or features suggesting steroid responsiveness, a long-acting beta2-agonist (LABA) and long-acting muscarinic antagonist (LAMA) should be added. If the patient is already taking a short-acting muscarinic antagonist (SAMA), it should be discontinued and switched to a short-acting beta2-agonist (SABA). If the patient has asthmatic features or features suggesting steroid responsiveness, a LABA and inhaled corticosteroid (ICS) should be added. If the patient remains breathless or has exacerbations, triple therapy (LAMA + LABA + ICS) should be offered.

NICE only recommends theophylline after trials of short and long-acting bronchodilators or to people who cannot use inhaled therapy. Azithromycin prophylaxis is recommended in select patients who have optimised standard treatments and continue to have exacerbations. Mucolytics should be considered in patients with a chronic productive cough and continued if symptoms improve.

Cor pulmonale features include peripheral oedema, raised jugular venous pressure, systolic parasternal heave, and loud P2. Loop diuretics should be used for oedema, and long-term oxygen therapy should be considered. Smoking cessation, long-term oxygen therapy in eligible patients, and lung volume reduction surgery in selected patients may improve survival in patients with stable COPD. NICE does not recommend the use of ACE-inhibitors, calcium channel blockers, or alpha blockers

The area of the vocal cords lacks lymphatic drainage, making it a lymphatic boundary. The upper portion above the vocal cords drains to the deep cervical nodes through vessels that penetrate the thyrohyoid membrane. The lower portion below the vocal cords drains to the pre-laryngeal, pre-tracheal, and inferior deep cervical nodes. The aryepiglottic and vestibular folds have a significant lymphatic drainage and are prone to early metastasis.

Anatomy of the Larynx

The larynx is located in the front of the neck, between the third and sixth cervical vertebrae. It is made up of several cartilaginous segments, including the paired arytenoid, corniculate, and cuneiform cartilages, as well as the single thyroid, cricoid, and epiglottic cartilages. The cricoid cartilage forms a complete ring. The laryngeal cavity extends from the laryngeal inlet to the inferior border of the cricoid cartilage and is divided into three parts: the laryngeal vestibule, the laryngeal ventricle, and the infraglottic cavity.

The vocal folds, also known as the true vocal cords, control sound production. They consist of the vocal ligament and the vocalis muscle, which is the most medial part of the thyroarytenoid muscle. The glottis is composed of the vocal folds, processes, and rima glottidis, which is the narrowest potential site within the larynx.

The larynx is also home to several muscles, including the posterior cricoarytenoid, lateral cricoarytenoid, thyroarytenoid, transverse and oblique arytenoids, vocalis, and cricothyroid muscles. These muscles are responsible for various actions, such as abducting or adducting the vocal folds and relaxing or tensing the vocal ligament.

The larynx receives its arterial supply from the laryngeal arteries, which are branches of the superior and inferior thyroid arteries. Venous drainage is via the superior and inferior laryngeal veins. Lymphatic drainage varies depending on the location within the larynx, with the vocal cords having no lymphatic drainage and the supraglottic and subglottic parts draining into different lymph nodes.

Overall, understanding the anatomy of the larynx is important for proper diagnosis and treatment of various conditions affecting this structure.

The patient’s medical history suggests that they may be suffering from alpha-1 antitrypsin deficiency.

When there is a shortage of alpha-1 antitrypsin, neutrophil elastase is not inhibited and can break down proteins in the lung interstitium. Although neutrophil elastase is a crucial part of the innate immune system, its unregulated activity can lead to excessive breakdown of extracellular proteins like elastin, collagen, fibronectin, and fibrin. This results in reduced pulmonary elasticity, which can cause emphysema and COPD.

Alpha-1 antitrypsin (A1AT) deficiency is a genetic condition that occurs when the liver does not produce enough of a protein called protease inhibitor (Pi). This protein is responsible for protecting cells from enzymes like neutrophil elastase. A1AT deficiency is inherited in an autosomal recessive or co-dominant manner and is located on chromosome 14. The alleles are classified by their electrophoretic mobility, with M being normal, S being slow, and Z being very slow. The normal genotype is PiMM, while heterozygous individuals have PiMZ. Homozygous PiSS individuals have 50% normal A1AT levels, while homozygous PiZZ individuals have only 10% normal A1AT levels.

A1AT deficiency is most commonly associated with panacinar emphysema, which is a type of chronic obstructive pulmonary disease (COPD). This is especially true for patients with the PiZZ genotype. Emphysema is more likely to occur in non-smokers with A1AT deficiency, but they may still pass on the gene to their children. In addition to lung problems, A1AT deficiency can also cause liver issues such as cirrhosis and hepatocellular carcinoma in adults, and cholestasis in children.

Diagnosis of A1AT deficiency involves measuring A1AT concentrations and performing spirometry to assess lung function. Management of the condition includes avoiding smoking and receiving supportive care such as bronchodilators and physiotherapy. Intravenous alpha1-antitrypsin protein concentrates may also be used. In severe cases, lung volume reduction surgery or lung transplantation may be necessary.

The presence of myasthenia gravis can result in a restrictive pattern of lung disease due to weakened chest wall muscles, leading to incomplete expansion during inhalation.

Occupational lung disease, also known as pneumoconioses, is caused by inhaling specific types of dust particles in the workplace, resulting in a restrictive pattern of lung disease. However, symptoms such as drooping eyelids and double vision are typically not associated with this condition.

Pneumonia is an infection of the lung tissue that typically presents with symptoms such as coughing, chest pain, fever, and difficulty breathing.

Pulmonary embolism is an acute condition that presents with symptoms such as chest pain, shortness of breath, and coughing up blood.

Understanding the Differences between Obstructive and Restrictive Lung Diseases

Obstructive and restrictive lung diseases are two distinct categories of respiratory conditions that affect the lungs in different ways. Obstructive lung diseases are characterized by a reduction in the flow of air through the airways due to narrowing or blockage, while restrictive lung diseases are characterized by a decrease in lung volume or capacity, making it difficult to breathe in enough air.

Spirometry is a common diagnostic tool used to differentiate between obstructive and restrictive lung diseases. In obstructive lung diseases, the ratio of forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) is less than 80%, indicating a reduced ability to exhale air. In contrast, restrictive lung diseases are characterized by an FEV1/FVC ratio greater than 80%, indicating a reduced ability to inhale air.

Examples of obstructive lung diseases include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and emphysema, while asthma and bronchiectasis are also considered obstructive. Restrictive lung diseases include intrapulmonary conditions such as idiopathic pulmonary fibrosis, extrinsic allergic alveolitis, and drug-induced fibrosis, as well as extrapulmonary conditions such as neuromuscular diseases, obesity, and scoliosis.

Understanding the differences between obstructive and restrictive lung diseases is important for accurate diagnosis and appropriate treatment. While both types of conditions can cause difficulty breathing, the underlying causes and treatment approaches can vary significantly.

The point at which the aorta, thoracic duct, and azygous vein cross the diaphragm is at T12, specifically at the aortic opening. This is also where the oesophageal branches of the left gastric veins, the vagal trunk, and the oesophagus pass through the diaphragm, at the oesophageal opening located at T10. The left phrenic nerve and sympathetic trunk have their own separate openings in the diaphragm. A lymph node in the left supraclavicular fossa, known as Virchow’s node, is a characteristic sign of early gastric carcinoma.

Structures Perforating the Diaphragm

The diaphragm is a dome-shaped muscle that separates the thoracic and abdominal cavities. It plays a crucial role in breathing by contracting and relaxing to create negative pressure in the lungs. However, there are certain structures that perforate the diaphragm, allowing them to pass through from the thoracic to the abdominal cavity. These structures include the inferior vena cava at the level of T8, the esophagus and vagal trunk at T10, and the aorta, thoracic duct, and azygous vein at T12.

To remember these structures and their corresponding levels, a helpful mnemonic is I 8(ate) 10 EGGS AT 12. This means that the inferior vena cava is at T8, the esophagus and vagal trunk are at T10, and the aorta, thoracic duct, and azygous vein are at T12. Knowing these structures and their locations is important for medical professionals, as they may need to access or treat them during surgical procedures or diagnose issues related to them.

Nasopharyngeal carcinoma is typically diagnosed through Trotter’s triad, which includes unilateral conductive hearing loss, ipsilateral facial and ear pain, and ipsilateral paralysis of the soft palate. This condition is commonly associated with previous Epstein Barr Virus infection, but there is no known link between the development of nasopharyngeal carcinoma and the other viruses mentioned.

Understanding Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma is a type of squamous cell carcinoma that affects the nasopharynx. It is a rare form of cancer that is more common in individuals from Southern China and is associated with Epstein Barr virus infection. The presenting features of nasopharyngeal carcinoma include cervical lymphadenopathy, otalgia, unilateral serous otitis media, nasal obstruction, discharge, and/or epistaxis, and cranial nerve palsies such as III-VI.

To diagnose nasopharyngeal carcinoma, a combined CT and MRI scan is typically used. The first line of treatment for this type of cancer is radiotherapy. It is important to catch nasopharyngeal carcinoma early to increase the chances of successful treatment.

The larynx receives sensory information from the laryngeal branches of the vagus.

Anatomy of the Larynx

The larynx is located in the front of the neck, between the third and sixth cervical vertebrae. It is made up of several cartilaginous segments, including the paired arytenoid, corniculate, and cuneiform cartilages, as well as the single thyroid, cricoid, and epiglottic cartilages. The cricoid cartilage forms a complete ring. The laryngeal cavity extends from the laryngeal inlet to the inferior border of the cricoid cartilage and is divided into three parts: the laryngeal vestibule, the laryngeal ventricle, and the infraglottic cavity.

The vocal folds, also known as the true vocal cords, control sound production. They consist of the vocal ligament and the vocalis muscle, which is the most medial part of the thyroarytenoid muscle. The glottis is composed of the vocal folds, processes, and rima glottidis, which is the narrowest potential site within the larynx.

The larynx is also home to several muscles, including the posterior cricoarytenoid, lateral cricoarytenoid, thyroarytenoid, transverse and oblique arytenoids, vocalis, and cricothyroid muscles. These muscles are responsible for various actions, such as abducting or adducting the vocal folds and relaxing or tensing the vocal ligament.

The larynx receives its arterial supply from the laryngeal arteries, which are branches of the superior and inferior thyroid arteries. Venous drainage is via the superior and inferior laryngeal veins. Lymphatic drainage varies depending on the location within the larynx, with the vocal cords having no lymphatic drainage and the supraglottic and subglottic parts draining into different lymph nodes.

Overall, understanding the anatomy of the larynx is important for proper diagnosis and treatment of various conditions affecting this structure.

The suprapleural membrane, also known as Sibson’s fascia, is located above the pleural cavity. The scalenus anterior muscle is positioned in front of the subclavian vein, while the subclavian artery is situated behind it.

Thoracic Outlet: Where the Subclavian Artery and Vein and Brachial Plexus Exit the Thorax

The thoracic outlet is the area where the subclavian artery and vein and the brachial plexus exit the thorax and enter the arm. This passage occurs over the first rib and under the clavicle. The subclavian vein is the most anterior structure and is located immediately in front of scalenus anterior and its attachment to the first rib. Scalenus anterior has two parts, and the subclavian artery leaves the thorax by passing over the first rib and between these two portions of the muscle. At the level of the first rib, the lower cervical nerve roots combine to form the three trunks of the brachial plexus. The lowest trunk is formed by the union of C8 and T1, and this trunk lies directly posterior to the artery and is in contact with the superior surface of the first rib.

Thoracic outlet obstruction can cause neurovascular compromise.

To calculate the total lung capacity, one can add the vital capacity and residual volume. For example, if the vital capacity is 3300 mL and the residual volume is 1200 mL, the total lung capacity would be 4500 mL. It is important to note that tidal volume, inspiratory capacity, and the FEV1/FVC ratio are other measurements related to lung function. Residual volume refers to the amount of air left in the lungs after a maximal exhalation, while total lung capacity refers to the volume of air in the lungs after a maximal inhalation.

Understanding Lung Volumes in Respiratory Physiology

In respiratory physiology, lung volumes can be measured to determine the amount of air that moves in and out of the lungs during breathing. The diagram above shows the different lung volumes that can be measured.

Tidal volume (TV) refers to the amount of air that is inspired or expired with each breath at rest. In males, the TV is 500ml while in females, it is 350ml.

Inspiratory reserve volume (IRV) is the maximum volume of air that can be inspired at the end of a normal tidal inspiration. The inspiratory capacity is the sum of TV and IRV. On the other hand, expiratory reserve volume (ERV) is the maximum volume of air that can be expired at the end of a normal tidal expiration.

Residual volume (RV) is the volume of air that remains in the lungs after maximal expiration. It increases with age and can be calculated by subtracting ERV from FRC. Speaking of FRC, it is the volume in the lungs at the end-expiratory position and is equal to the sum of ERV and RV.

Vital capacity (VC) is the maximum volume of air that can be expired after a maximal inspiration. It decreases with age and can be calculated by adding inspiratory capacity and ERV. Lastly, total lung capacity (TLC) is the sum of vital capacity and residual volume.

Physiological dead space (VD) is calculated by multiplying tidal volume by the difference between arterial carbon dioxide pressure (PaCO2) and end-tidal carbon dioxide pressure (PeCO2) and then dividing the result by PaCO2.

The patient’s pulmonary function tests indicate a restrictive pattern, as both FEV1 and FVC are reduced. This suggests a possible neuromuscular disorder, as all other options would result in an obstructive pattern on the tests. Asthma, bronchiectasis, and COPD are unlikely diagnoses for a 20-year-old and would not match the test results. Pneumonia may affect the patient’s ability to perform the tests, but it is typically an acute condition that requires immediate treatment with antibiotics.

Understanding Pulmonary Function Tests

Pulmonary function tests are a useful tool in determining whether a respiratory disease is obstructive or restrictive. These tests measure various aspects of lung function, such as forced expiratory volume in one second (FEV1) and forced vital capacity (FVC). By analyzing the results of these tests, doctors can diagnose and monitor conditions such as asthma, COPD, pulmonary fibrosis, and neuromuscular disorders.

In obstructive lung diseases, such as asthma and COPD, the FEV1 is significantly reduced, while the FVC may be reduced or normal. The FEV1% (FEV1/FVC) is also reduced. On the other hand, in restrictive lung diseases, such as pulmonary fibrosis and asbestosis, the FEV1 is reduced, but the FVC is significantly reduced. The FEV1% (FEV1/FVC) may be normal or increased.

It is important to note that there are many conditions that can affect lung function, and pulmonary function tests are just one tool in diagnosing and managing respiratory diseases. However, understanding the results of these tests can provide valuable information for both patients and healthcare providers.

It is rare for a foreign object to become lodged in the left mainstem bronchus due to its greater angle compared to the right mainstem bronchus. A tracheal obstruction would cause reduced breath sounds bilaterally, not just on one side. The right superior lobar bronchus is also unlikely to be affected due to its angle and direction. Therefore, foreign bodies typically get stuck in the right mainstem bronchus in adults because of its wider diameter and lesser angle.

Anatomy of the Lungs

The lungs are a pair of organs located in the chest cavity that play a vital role in respiration. The right lung is composed of three lobes, while the left lung has two lobes. The apex of both lungs is approximately 4 cm superior to the sternocostal joint of the first rib. The base of the lungs is in contact with the diaphragm, while the costal surface corresponds to the cavity of the chest. The mediastinal surface contacts the mediastinal pleura and has the cardiac impression. The hilum is a triangular depression above and behind the concavity, where the structures that form the root of the lung enter and leave the viscus. The right main bronchus is shorter, wider, and more vertical than the left main bronchus. The inferior borders of both lungs are at the 6th rib in the mid clavicular line, 8th rib in the mid axillary line, and 10th rib posteriorly. The pleura runs two ribs lower than the corresponding lung level. The bronchopulmonary segments of the lungs are divided into ten segments, each with a specific function.

If a patient presents with raised serum ACE levels, sarcoidosis should be considered as a possible diagnosis. The combination of erythema nodosum and bilateral hilar lymphadenopathy on a chest x-ray is pathognomonic of sarcoidosis. Lung cancer is unlikely in a young patient without a significant smoking history, and tuberculosis would require recent foreign travel to a TB endemic country. Multiple myeloma would not cause the same symptoms as sarcoidosis. Exposure to organic material would not be a likely cause of raised serum ACE levels.

Understanding Sarcoidosis: A Multisystem Disorder

Sarcoidosis is a condition that affects multiple systems in the body and is characterized by the presence of non-caseating granulomas. The exact cause of this disorder is unknown, but it is more commonly seen in young adults and individuals of African descent.

The symptoms of sarcoidosis can vary depending on the severity of the condition. Acute symptoms may include erythema nodosum, bilateral hilar lymphadenopathy, swinging fever, and polyarthralgia. On the other hand, insidious symptoms may include dyspnea, non-productive cough, malaise, and weight loss. Additionally, some individuals may develop skin symptoms such as lupus pernio, while others may experience hypercalcemia due to increased conversion of vitamin D to its active form.

Sarcoidosis is also associated with several syndromes, including Lofgren’s syndrome, Mikulicz syndrome, and Heerfordt’s syndrome. Lofgren’s syndrome is an acute form of the disease that typically presents with bilateral hilar lymphadenopathy, erythema nodosum, fever, and polyarthralgia. Mikulicz syndrome is characterized by enlargement of the parotid and lacrimal glands due to sarcoidosis, tuberculosis, or lymphoma. Finally, Heerfordt’s syndrome, also known as uveoparotid fever, presents with parotid enlargement, fever, and uveitis secondary to sarcoidosis.

In conclusion, sarcoidosis is a complex disorder that can affect multiple systems in the body. While the exact cause is unknown, early diagnosis and treatment can help manage symptoms and improve outcomes.

The patient is exhibiting symptoms and ABG results consistent with respiratory alkalosis. However, it is important to conduct a thorough history and physical examination to rule out any underlying pulmonary pathology or infection. Based on the patient’s history, anxiety-induced hyperventilation is the most probable cause of her condition.

Respiratory Alkalosis: Causes and Examples

Respiratory alkalosis is a condition that occurs when the blood pH level rises above the normal range due to excessive breathing. This can be caused by various factors, including anxiety, pulmonary embolism, CNS disorders, altitude, and pregnancy. Salicylate poisoning can also lead to respiratory alkalosis, but it may also cause metabolic acidosis in the later stages. In this case, the respiratory centre is stimulated early, leading to respiratory alkalosis, while the direct acid effects of salicylates combined with acute renal failure may cause acidosis later on. It is important to identify the underlying cause of respiratory alkalosis to determine the appropriate treatment. Proper management can help prevent complications and improve the patient’s overall health.

Methaemoglobin causes a leftward shift of the oxygen dissociation curve, indicating an increased affinity of haemoglobin for oxygen. This results in reduced offloading of oxygen into the tissues, leading to decreased oxygen delivery. It is important to understand the oxygen-dissociation curve and the effects of carbon monoxide poisoning, which causes increased oxygen binding to methaemoglobin. A rightward shift of the curve indicates increased oxygen delivery to the tissues, which is not the case in methaemoglobinemia.

Understanding the Oxygen Dissociation Curve

The oxygen dissociation curve is a graphical representation of the relationship between the percentage of saturated haemoglobin and the partial pressure of oxygen in the blood. It is not influenced by the concentration of haemoglobin. The curve can shift to the left or right, indicating changes in oxygen delivery to tissues. When the curve shifts to the left, there is increased saturation of haemoglobin with oxygen, resulting in decreased oxygen delivery to tissues. Conversely, when the curve shifts to the right, there is reduced saturation of haemoglobin with oxygen, leading to enhanced oxygen delivery to tissues.

The L rule is a helpful mnemonic to remember the factors that cause a shift to the left, resulting in lower oxygen delivery. These factors include low levels of hydrogen ions (alkali), low partial pressure of carbon dioxide, low levels of 2,3-diphosphoglycerate, and low temperature. On the other hand, the mnemonic ‘CADET, face Right!’ can be used to remember the factors that cause a shift to the right, leading to raised oxygen delivery. These factors include carbon dioxide, acid, 2,3-diphosphoglycerate, exercise, and temperature.

Understanding the oxygen dissociation curve is crucial in assessing the oxygen-carrying capacity of the blood and the delivery of oxygen to tissues. By knowing the factors that can shift the curve to the left or right, healthcare professionals can make informed decisions in managing patients with respiratory and cardiovascular diseases.

The chorda tympani is the correct answer. It is a branch of the seventh cranial nerve, the facial nerve, and carries parasympathetic and taste fibers. It passes through the middle ear before exiting and joining with the lingual nerve to reach the tongue and salivary glands.

The vestibulocochlear nerve is the eighth cranial nerve and carries balance and hearing information.

The maxillary nerve is the second division of the fifth cranial nerve and carries sensation from the upper teeth, nasal cavity, and skin.

The mandibular nerve is the third division of the fifth cranial nerve and carries sensation from the lower teeth, tongue, mandible, and skin. It also carries motor fibers to certain muscles.

The glossopharyngeal nerve is the ninth cranial nerve and carries taste and sensation from the posterior one-third of the tongue, as well as sensation from various areas. It also carries motor and parasympathetic fibers.

The patient in the question has ear pain, likely due to otitis media, as evidenced by a bulging tympanic membrane and fluid level on otoscopy.

Anatomy of the Ear

The ear is divided into three distinct regions: the external ear, middle ear, and internal ear. The external ear consists of the auricle and external auditory meatus, which are innervated by the greater auricular nerve and auriculotemporal branch of the trigeminal nerve. The middle ear is the space between the tympanic membrane and cochlea, and is connected to the nasopharynx by the eustachian tube. The tympanic membrane is composed of three layers and is approximately 1 cm in diameter. The middle ear is innervated by the glossopharyngeal nerve. The ossicles, consisting of the malleus, incus, and stapes, transmit sound vibrations from the tympanic membrane to the inner ear. The internal ear contains the cochlea, which houses the organ of corti, the sense organ of hearing. The vestibule accommodates the utricule and saccule, which contain endolymph and are surrounded by perilymph. The semicircular canals, which share a common opening into the vestibule, lie at various angles to the petrous temporal bone.

The most likely diagnosis for this patient is granulomatosis with polyangiitis, as indicated by the presence of cANCA and the involvement of multiple organs including the lungs, skin, kidneys, and upper respiratory tract. This condition is known to cause inflammation in the glomeruli, leading to renal impairment. Churg-Strauss disease and Alport’s syndrome are unlikely due to normal eosinophil levels and cANCA positivity, respectively. Goodpasture’s syndrome is also unlikely as the patient does not present with haematuria or haemoptysis.

Granulomatosis with Polyangiitis: An Autoimmune Condition

Granulomatosis with polyangiitis, previously known as Wegener’s granulomatosis, is an autoimmune condition that affects the upper and lower respiratory tract as well as the kidneys. It is characterized by a necrotizing granulomatous vasculitis. The condition presents with various symptoms such as epistaxis, sinusitis, nasal crusting, dyspnoea, haemoptysis, and rapidly progressive glomerulonephritis. Other symptoms include a saddle-shape nose deformity, vasculitic rash, eye involvement, and cranial nerve lesions.

To diagnose granulomatosis with polyangiitis, doctors perform various investigations such as cANCA and pANCA tests, chest x-rays, and renal biopsies. The cANCA test is positive in more than 90% of cases, while the pANCA test is positive in 25% of cases. Chest x-rays show a wide variety of presentations, including cavitating lesions. Renal biopsies reveal epithelial crescents in Bowman’s capsule.

The management of granulomatosis with polyangiitis involves the use of steroids, cyclophosphamide, and plasma exchange. Cyclophosphamide has a 90% response rate. The median survival rate for patients with this condition is 8-9 years.

To calculate the volume of air in the lungs after a normal relaxed expiration, one can use the formula for functional residual capacity (FRC), which is determined by the balance between the lungs’ tendency to recoil inwards and the chest wall’s tendency to pull outwards. FRC can be calculated by adding the expiratory reserve volume and the residual volume. In individuals with tetraplegia, decreases in FRC are primarily caused by a reduction in the outward pull of the chest wall, which occurs over time due to the inability to regularly expand the chest wall to large lung volumes. This reduction in FRC can increase the risk of atelectasis.

Understanding Lung Volumes in Respiratory Physiology

In respiratory physiology, lung volumes can be measured to determine the amount of air that moves in and out of the lungs during breathing. The diagram above shows the different lung volumes that can be measured.

Tidal volume (TV) refers to the amount of air that is inspired or expired with each breath at rest. In males, the TV is 500ml while in females, it is 350ml.

Inspiratory reserve volume (IRV) is the maximum volume of air that can be inspired at the end of a normal tidal inspiration. The inspiratory capacity is the sum of TV and IRV. On the other hand, expiratory reserve volume (ERV) is the maximum volume of air that can be expired at the end of a normal tidal expiration.

Residual volume (RV) is the volume of air that remains in the lungs after maximal expiration. It increases with age and can be calculated by subtracting ERV from FRC. Speaking of FRC, it is the volume in the lungs at the end-expiratory position and is equal to the sum of ERV and RV.

Vital capacity (VC) is the maximum volume of air that can be expired after a maximal inspiration. It decreases with age and can be calculated by adding inspiratory capacity and ERV. Lastly, total lung capacity (TLC) is the sum of vital capacity and residual volume.

Physiological dead space (VD) is calculated by multiplying tidal volume by the difference between arterial carbon dioxide pressure (PaCO2) and end-tidal carbon dioxide pressure (PeCO2) and then dividing the result by PaCO2.

Understanding Cystic Fibrosis

Cystic fibrosis is a genetic disorder that causes thickened secretions in the lungs and pancreas. It is an autosomal recessive condition that occurs due to a defect in the cystic fibrosis transmembrane conductance regulator gene (CFTR), which regulates a chloride channel. In the UK, 80% of CF cases are caused by delta F508 on chromosome 7, and the carrier rate is approximately 1 in 25.

CF patients are at risk of colonization by certain organisms, including Staphylococcus aureus, Pseudomonas aeruginosa, Burkholderia cepacia (previously known as Pseudomonas cepacia), and Aspergillus. These organisms can cause infections and exacerbate symptoms in CF patients. It is important for healthcare providers to monitor and manage these infections to prevent further complications.

Overall, understanding cystic fibrosis and its associated risks can help healthcare providers provide better care for patients with this condition.

The phrenic nerves, located in the anterior region of the lung’s hilum, play a crucial role in keeping the diaphragm functioning properly. These nerves have both sensory and motor functions, and any issues in the sub diaphragmatic area may result in referred pain in the shoulder.

The Phrenic Nerve: Origin, Path, and Supplies

The phrenic nerve is a crucial nerve that originates from the cervical spinal nerves C3, C4, and C5. It supplies the diaphragm and provides sensation to the central diaphragm and pericardium. The nerve passes with the internal jugular vein across scalenus anterior and deep to the prevertebral fascia of the deep cervical fascia.

The right phrenic nerve runs anterior to the first part of the subclavian artery in the superior mediastinum and laterally to the superior vena cava. In the middle mediastinum, it is located to the right of the pericardium and passes over the right atrium to exit the diaphragm at T8. On the other hand, the left phrenic nerve passes lateral to the left subclavian artery, aortic arch, and left ventricle. It passes anterior to the root of the lung and pierces the diaphragm alone.

Understanding the origin, path, and supplies of the phrenic nerve is essential in diagnosing and treating conditions that affect the diaphragm and pericardium.

As a junior doctor, you will often encounter patients who retain carbon dioxide and depend on their hypoxic drive to breathe. When using Venturi masks to deliver controlled oxygen, it is important to set a target that balances the patient’s need for oxygen with their reliance on hypoxia to stimulate breathing. Answer 4 is the correct choice in this scenario. Providing too much oxygen, as in answers 2 and 3, can cause the patient to lose their hypoxic drive and become drowsy or confused. Answer 5 does not provide enough oxygen to properly perfuse the tissues. Failing to set a target for these patients is not good clinical practice.

Guidelines for Oxygen Therapy in Emergency Situations

In 2017, the British Thoracic Society updated its guidelines for emergency oxygen therapy. The guidelines state that in critically ill patients, such as those experiencing anaphylaxis or shock, oxygen should be administered through a reservoir mask at a rate of 15 liters per minute. However, certain conditions, such as stable myocardial infarction, are excluded from this recommendation.

The guidelines also provide specific oxygen saturation targets for different patient populations. Acutely ill patients should have a saturation level between 94-98%, while patients at risk of hypercapnia, such as those with COPD, should have a saturation level between 88-92%. Oxygen levels should be reduced in stable patients with satisfactory oxygen saturation.

For COPD patients, a 28% Venturi mask at 4 liters per minute should be used prior to the availability of blood gases. The target oxygen saturation level for these patients should be 88-92% if they have risk factors for hypercapnia but no prior history of respiratory acidosis. If the patient’s pCO2 is normal, the target range should be adjusted to 94-98%.

The guidelines also state that oxygen therapy should not be used routinely in certain situations where there is no evidence of hypoxia, such as in cases of myocardial infarction, acute coronary syndromes, stroke, obstetric emergencies, and anxiety-related hyperventilation.

Overall, these guidelines provide important recommendations for the appropriate use of oxygen therapy in emergency situations, taking into account the specific needs of different patient populations.

Arterial carbon dioxide stimulates them, but it takes longer to reach equilibrium compared to the carotid peripheral chemoreceptors. They are not as responsive to acidity because of the blood-brain barrier.

The Control of Ventilation in the Human Body

The control of ventilation in the human body is a complex process that involves various components working together to regulate the respiratory rate and depth of respiration. The respiratory centres, chemoreceptors, lung receptors, and muscles all play a role in this process. The automatic, involuntary control of respiration occurs from the medulla, which is responsible for controlling the respiratory rate and depth of respiration.

The respiratory centres consist of the medullary respiratory centre, apneustic centre, and pneumotaxic centre. The medullary respiratory centre has two groups of neurons, the ventral group, which controls forced voluntary expiration, and the dorsal group, which controls inspiration. The apneustic centre, located in the lower pons, stimulates inspiration and activates and prolongs inhalation. The pneumotaxic centre, located in the upper pons, inhibits inspiration at a certain point and fine-tunes the respiratory rate.

Ventilatory variables, such as the levels of pCO2, are the most important factors in ventilation control, while levels of O2 are less important. Peripheral chemoreceptors, located in the bifurcation of carotid arteries and arch of the aorta, respond to changes in reduced pO2, increased H+, and increased pCO2 in arterial blood. Central chemoreceptors, located in the medulla, respond to increased H+ in brain interstitial fluid to increase ventilation. It is important to note that the central receptors are not influenced by O2 levels.

Lung receptors also play a role in the control of ventilation. Stretch receptors respond to lung stretching, causing a reduced respiratory rate, while irritant receptors respond to smoke, causing bronchospasm. J (juxtacapillary) receptors are also involved in the control of ventilation. Overall, the control of ventilation is a complex process that involves various components working together to regulate the respiratory rate and depth of respiration.

The patient’s medical background indicates that she may have atopic asthma. It is probable that her symptoms have worsened and she has had to use more salbutamol reliever due to an allergy to her new kitten’s animal dander.

Individuals with allergic asthma have been found to have increased levels of eosinophils in their airways. The severity of asthma is linked to the number of eosinophils present, as they contribute to long-term airway inflammation by causing damage, blockages, and hyperresponsiveness.

The immediate symptoms of asthma after exposure are caused by mast cell degranulation.

Asthma is a common respiratory disorder that affects both children and adults. It is characterized by chronic inflammation of the airways, resulting in reversible bronchospasm and airway obstruction. While asthma can develop at any age, it typically presents in childhood and may improve or resolve with age. However, it can also persist into adulthood and cause significant morbidity, with around 1,000 deaths per year in the UK.

Several risk factors can increase the likelihood of developing asthma, including a personal or family history of atopy, antenatal factors such as maternal smoking or viral infections, low birth weight, not being breastfed, exposure to allergens and air pollution, and the hygiene hypothesis. Patients with asthma may also suffer from other atopic conditions such as eczema and hay fever, and some may be sensitive to aspirin. Occupational asthma is also a concern for those exposed to allergens in the workplace.

Symptoms of asthma include coughing, dyspnea, wheezing, and chest tightness, with coughing often worse at night. Signs may include expiratory wheezing on auscultation and reduced peak expiratory flow rate. Diagnosis is typically made through spirometry, which measures the volume and speed of air during exhalation and inhalation.

Management of asthma typically involves the use of inhalers to deliver drug therapy directly to the airways. Short-acting beta-agonists such as salbutamol are the first-line treatment for relieving symptoms, while inhaled corticosteroids like beclometasone dipropionate and fluticasone propionate are used for daily maintenance therapy. Long-acting beta-agonists like salmeterol and leukotriene receptor antagonists like montelukast may also be used in combination with other medications. Maintenance and reliever therapy (MART) is a newer approach that combines ICS and a fast-acting LABA in a single inhaler for both daily maintenance and symptom relief. Recent guidelines recommend offering a leukotriene receptor antagonist instead of a LABA for patients on SABA + ICS whose asthma is not well controlled, and considering MART for those with poorly controlled asthma.